Published in Epidemiology on May 01, 2002
The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol (2010) 3.08
Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol (2008) 2.79
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat (2007) 2.27
Statin use and risk of prostate cancer: a meta-analysis of observational studies. PLoS One (2012) 1.74
Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age. Cancer Epidemiol Biomarkers Prev (2013) 1.59
Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf (2010) 1.56
Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control (2008) 1.47
Statins and colorectal cancer. Clin Gastroenterol Hepatol (2012) 1.36
Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev (2007) 1.31
Statin use and fatal prostate cancer: a matched case-control study. Cancer (2011) 1.28
Targeted therapy for breast cancer prevention. Front Oncol (2013) 1.12
Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiol Biomarkers Prev (2013) 1.01
Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study. Cancer Epidemiol (2010) 0.85
Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer. Curr Breast Cancer Rep (2014) 0.83
Statin use and the risk of colorectal cancer: a population-based case-control study. World J Gastroenterol (2011) 0.82
Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget (2016) 0.81
Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy. Mol Clin Oncol (2012) 0.80
Chinese red yeast rice inhibition of prostate tumor growth in SCID mice. Cancer Prev Res (Phila) (2011) 0.80
Statins and Breast Cancer: Future Directions in Chemoprevention. Curr Breast Cancer Rep (2013) 0.78
Statins and cancer: will we ever know the answer? Epidemiology (2002) 0.76
Elevated K-ras activity with cholestyramine and lovastatin, but not konjac mannan or niacin in lung--importance of mouse strain. Biochem Pharmacol (2006) 0.76
Effect of Lipophilic and Hydrophilic Statins on Breast Cancer Risk in Thai Women: A Cross-sectional Study. J Cancer (2016) 0.75
Statins are Associated With a Reduced Risk of Brain Cancer: A Population-Based Case-Control Study. Medicine (Baltimore) (2016) 0.75
Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors. Am J Epidemiol (2017) 0.75
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA (2002) 10.03
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med (2014) 6.54
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care (2011) 5.63
Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol (2003) 4.27
Design of a national distributed health data network. Ann Intern Med (2009) 4.09
Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Intern Med (2008) 4.03
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation (2005) 3.28
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Statin use and the risk of 10 cancers. Epidemiology (2007) 3.17
Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol (2004) 3.07
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res (2006) 3.06
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05
Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage (2003) 3.05
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90
Air pollution and incidence of hypertension and diabetes mellitus in black women living in Los Angeles. Circulation (2012) 2.78
The FDA and drug safety: a proposal for sweeping changes. Arch Intern Med (2006) 2.74
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation (2006) 2.68
Recent trends in use of herbal and other natural products. Arch Intern Med (2005) 2.65
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS (2006) 2.57
Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev (2013) 2.56
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology (2008) 2.56
Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA (2003) 2.51
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut (2013) 2.50
Prevalence and characteristics of opioid use in the US adult population. Pain (2008) 2.49
Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2008) 2.47
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) (2009) 2.46
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medications. Am J Gastroenterol (2002) 2.39
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study. Cancer Causes Control (2008) 2.35
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction. Ann Intern Med (2005) 2.34
Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology (2005) 2.33
The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol (2007) 2.32
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31
General and abdominal obesity and risk of death among black women. N Engl J Med (2011) 2.27
The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol (2002) 2.21
Validation of 6-minute walk distance as a surrogate end point in pulmonary arterial hypertension trials. Circulation (2012) 2.19
Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol (2005) 2.18
Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med (2013) 2.16
Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med (2011) 2.16
Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf (2002) 2.12
Relative validity of food frequency questionnaire nutrient estimates in the Black Women's Health Study. Ann Epidemiol (2003) 2.11
Socioeconomic status and incidence of type 2 diabetes: results from the Black Women's Health Study. Am J Epidemiol (2010) 2.10
White paper on CTSA consortium role in facilitating comparative effectiveness research: September 23, 2009 CTSA consortium strategic goal committee on comparative effectiveness research. Clin Transl Sci (2010) 2.09
Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets. J Fam Plann Reprod Health Care (2011) 2.07
Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis (2008) 2.03
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs. Pharmacoepidemiol Drug Saf (2013) 2.01
Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care (2006) 1.98
Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96
Fruit and vegetable intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst (2013) 1.94
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89
At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer (2009) 1.88
Cardiovascular events and death in children exposed and unexposed to ADHD agents. Pediatrics (2011) 1.84
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis (2004) 1.83
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care (2011) 1.83
National Polyp Study data: evidence for regression of adenomas. Int J Cancer (2004) 1.83
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control (2010) 1.82
Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol (2008) 1.80
Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf (2010) 1.78
A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev (2007) 1.77
A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making (2011) 1.77
Racial discrimination and breast cancer incidence in US Black women: the Black Women's Health Study. Am J Epidemiol (2007) 1.77
The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin. J Am Coll Cardiol (2004) 1.76
Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst (2005) 1.75
The advanced adenoma as the primary target of screening. Gastrointest Endosc Clin N Am (2002) 1.73
Type 2 diabetes and the risk of colorectal adenomas: Black Women's Health Study. Am J Epidemiol (2013) 1.72
A case-control study of oral contraceptive use and incident breast cancer. Am J Epidemiol (2008) 1.72
Clarifying differences in natural history between models of screening: the case of colorectal cancer. Med Decis Making (2011) 1.71
A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer (2007) 1.71
Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev (2011) 1.71
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst (2012) 1.69
Glycemic index, glycemic load, and cereal fiber intake and risk of type 2 diabetes in US black women. Arch Intern Med (2007) 1.67